Zhejiang Xianju Pharmaceutical Co Ltd Cash Flow Reinvestment Rate
Zhejiang Xianju Pharmaceutical Co Ltd cash flow reinvestment rate. Zhejiang Xianju Pharmaceutical Co Ltd (002332) has a Cash Flow Reinvestment Rate of 0.23x as of September 2025, reinvesting CN¥30.01 Million (capex CN¥30.01 Million ) from operating cash flow of CN¥130.05 Million. Explore 002332 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Zhejiang Xianju Pharmaceutical Co Ltd (2006–2025)
Cash flow reinvestment rate of Zhejiang Xianju Pharmaceutical Co Ltd from 2006 to 2025. Historical reinvestment intensity for Zhejiang Xianju Pharmaceutical Co Ltd across 20 annual periods. Explore Zhejiang Xianju Pharmaceutical Co Ltd (002332) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
Zhejiang Xianju Pharmaceutical Co Ltd Cash Flow Reinvestment Rate by Year (2006–2025)
Zhejiang Xianju Pharmaceutical Co Ltd cash flow reinvestment rate by year from 2006 to 2025. Year-by-year capital reinvestment analysis for Zhejiang Xianju Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see cash flow conversion of Zhejiang Xianju Pharmaceutical Co Ltd.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.85x | CN¥210.78 Million | CN¥247.48 Million | CN¥209.07 Million | ▲ +49.1% |
| 2024 | 0.57x | CN¥227.68 Million | CN¥398.66 Million | CN¥207.59 Million | ▼ -21.1% |
| 2023 | 0.72x | CN¥431.26 Million | CN¥595.48 Million | CN¥234.63 Million | ▼ -31.1% |
| 2022 | 1.05x | CN¥640.61 Million | CN¥609.28 Million | CN¥282.54 Million | ▲ +160.0% |
| 2021 | 0.40x | CN¥273.38 Million | CN¥676.15 Million | CN¥266.84 Million | ▼ -46.5% |
| 2020 | 0.76x | CN¥596.55 Million | CN¥789.23 Million | CN¥118.17 Million | ▲ +32.7% |
| 2019 | 0.57x | CN¥296.18 Million | CN¥519.81 Million | CN¥262.34 Million | ▼ -61.7% |
| 2018 | 1.49x | CN¥287.70 Million | CN¥193.27 Million | CN¥169.26 Million | ▼ -1.5% |
| 2017 | 1.51x | CN¥253.16 Million | CN¥167.47 Million | CN¥123.28 Million | ▲ +77.1% |
| 2016 | 0.85x | CN¥133.11 Million | CN¥155.91 Million | CN¥97.10 Million | ▼ -65.9% |
| 2015 | 2.50x | CN¥499.17 Million | CN¥199.61 Million | CN¥115.05 Million | ▲ +227.2% |
| 2014 | 0.76x | CN¥108.26 Million | CN¥141.64 Million | CN¥108.26 Million | ▼ -74.4% |
| 2013 | 2.98x | CN¥189.26 Million | CN¥63.46 Million | CN¥189.26 Million | ▼ -66.5% |
| 2012 | 8.91x | CN¥298.01 Million | CN¥33.43 Million | CN¥298.01 Million | ▲ +380.1% |
| 2011 | 1.86x | CN¥274.14 Million | CN¥147.63 Million | CN¥274.14 Million | ▲ +360.8% |
| 2010 | 0.40x | CN¥62.58 Million | CN¥155.29 Million | CN¥62.58 Million | ▼ -1.8% |
| 2009 | 0.41x | CN¥42.94 Million | CN¥104.68 Million | CN¥42.94 Million | ▼ -75.1% |
| 2008 | 1.64x | CN¥59.25 Million | CN¥36.03 Million | CN¥59.25 Million | ▲ +135.0% |
| 2007 | 0.70x | CN¥67.55 Million | CN¥96.53 Million | CN¥67.55 Million | ▲ +1.7% |
| 2006 | 0.69x | CN¥36.51 Million | CN¥53.05 Million | CN¥36.51 Million | — |